Bu öğeden alıntı yapmak, öğeye bağlanmak için bu tanımlayıcıyı kullanınız: http://hdl.handle.net/11452/25469
Tüm üstveri kaydı
Dublin Core AlanıDeğerDil
dc.contributor.authorWehrend, Axel-
dc.date.accessioned2022-03-31T06:15:30Z-
dc.date.available2022-03-31T06:15:30Z-
dc.date.issued2010-06-
dc.identifier.citationÖzalp, G. R. vd. (2010). "Effects of the progesterone receptor antagonist aglepristone on implantation administered on days 6 and 7 after mating in rabbits". Reproduction in Domestic Animals, 45(3), 505-508.en_US
dc.identifier.issn0936-6768-
dc.identifier.issn1439-0531-
dc.identifier.urihttps://doi.org/10.1111/j.1439-0531.2008.01282.x-
dc.identifier.urihttps://onlinelibrary.wiley.com/doi/10.1111/j.1439-0531.2008.01282.x-
dc.identifier.urihttp://hdl.handle.net/11452/25469-
dc.description.abstractContents There is no safe and accurate method for early termination of pregnancy in the rabbit. So this study was carried out to determine the effect of aglepristone administration in preventing early pregnancy before implantation in this species. Twenty-two animals (10-12 months old, New Zealand White rabbits) were naturally mated and pregnancies were confirmed in all animals by ultrasonographic examinations on day 6 after mating (5-7.5 MHz linear array transducer Dynamic Imaging Sonostar, UK) and the animals were grouped randomly: Group I & Group III: Aglepristone (Alizin (R), Virbac; 10 mg/kg, subcutaneously) was injected twice, 24 h apart, on days 6 and 7 after mating (n = 5; n = 8). Group II & Group IV: The same volume of 0.9% NaCl solution was subcutaneously injected in the same interval and served as controls (n = 5; n = 3). Ultrasonographical examination of the uterus was performed daily from day 7 to day 11 post-mating to test aglepristone efficiency. Blood samples were collected between days 6 and 30, centrifuged at 3070 g for 10 min and stored at -20 degrees C. The does in aglepristone groups (Group I, III) were not pregnant whereas all animals in control groups were pregnant (Group II, IV). The does in group I & III were examined only clinically and ultrasonographically; however, does in groups III and IV were laparomized on days 6, 7, 9 and 11 post-mating to control countable implantation sites. No implantation sites were present in group III whereas they were seen obviously in group IV. Side effects were not observed. The mean serum progesterone (P4) concentrations were not significantly different between control and treated does (p > 0.05). The results indicate that aglepristone treatment on days 6 and 7 after mating could prevent pregnancy after unwanted matings without any side effects in the rabbit. Aglepristone treatments are possibly not affecting further fertilities before implantation.en_US
dc.language.isoenen_US
dc.publisherWileyen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectMidgestation pregnancy terminationen_US
dc.subjectPreventionen_US
dc.subjectAnordrinen_US
dc.subjectBitchesen_US
dc.subjectQueensen_US
dc.subjectRU-486en_US
dc.subjectAgricultureen_US
dc.subjectReproductive biologyen_US
dc.subjectVeterinary sciencesen_US
dc.subjectAnimaliaen_US
dc.subjectOryctolagus cuniculusen_US
dc.subject.meshAbortifacient agents, steroidalen_US
dc.subject.meshAnimalsen_US
dc.subject.meshBreedingen_US
dc.subject.meshEmbryo implantationen_US
dc.subject.meshEstrenesen_US
dc.subject.meshFemaleen_US
dc.subject.meshMaleen_US
dc.subject.meshPregnancyen_US
dc.subject.meshRabbitsen_US
dc.subject.meshRandom allocationen_US
dc.subject.meshReceptors, progesteroneen_US
dc.subject.meshTime factorsen_US
dc.subject.meshUterusen_US
dc.titleEffects of the progesterone receptor antagonist aglepristone on implantation administered on days 6 and 7 after mating in rabbitsen_US
dc.typeArticleen_US
dc.identifier.wos000277873000021tr_TR
dc.identifier.scopus2-s2.0-77954119999tr_TR
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergitr_TR
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/Kadın Hastalıkları ve Doğum Anabilim Dalı.tr_TR
dc.contributor.orcid0000-0003-4694-6937tr_TR
dc.identifier.startpage505tr_TR
dc.identifier.endpage508tr_TR
dc.identifier.volume45tr_TR
dc.identifier.issue3tr_TR
dc.relation.journalReproduction in Domestic Animalsen_US
dc.contributor.buuauthorÖzalp, Gözde Rabia-
dc.contributor.buuauthorÇalışkan, Çağlar-
dc.contributor.buuauthorSeyrek İntaş, Kamil-
dc.contributor.researcheridAAE-3607-2019tr_TR
dc.contributor.researcheridAAH-7292-2019tr_TR
dc.relation.collaborationYurt dışıtr_TR
dc.identifier.pubmed19019074tr_TR
dc.subject.wosAgriculture, dairy & animal scienceen_US
dc.subject.wosReproductive biologyen_US
dc.subject.wosVeterinary sciencesen_US
dc.indexed.wosSCIEen_US
dc.indexed.scopusScopusen_US
dc.indexed.pubmedPubMeden_US
dc.wos.quartileQ1en_US
dc.wos.quartileQ4 (Reproductive biology)en_US
dc.contributor.scopusid23985710500tr_TR
dc.contributor.scopusid23984353800tr_TR
dc.contributor.scopusid6603409870tr_TR
dc.subject.scopusPyometra; Bitches; Deslorelinen_US
dc.subject.emtreeAbortive agenten_US
dc.subject.emtreeAglepristoneen_US
dc.subject.emtreeEstrane derivativeen_US
dc.subject.emtreeProgesterone receptoren_US
dc.subject.emtreeAbortive agenten_US
dc.subject.emtreeAglepristoneen_US
dc.subject.emtreeEstrane derivativeen_US
dc.subject.emtreeProgesterone receptoren_US
dc.subject.emtreeAnimalen_US
dc.subject.emtreeArticleen_US
dc.subject.emtreeBreedingen_US
dc.subject.emtreeDrug antagonismen_US
dc.subject.emtreeDrug effecten_US
dc.subject.emtreeFemaleen_US
dc.subject.emtreeMaleen_US
dc.subject.emtreeNidationen_US
dc.subject.emtreePhysiologyen_US
dc.subject.emtreePregnancyen_US
dc.subject.emtreeRabbiten_US
dc.subject.emtreeRandomizationen_US
dc.subject.emtreeTimeen_US
dc.subject.emtreeUltrastructureen_US
dc.subject.emtreeUterusen_US
dc.subject.emtreeAntagonists and inhibitorsen_US
Koleksiyonlarda Görünür:PubMed
Scopus
Web of Science

Bu öğenin dosyaları:
Bu öğeyle ilişkili dosya bulunmamaktadır.


DSpace'deki bütün öğeler, aksi belirtilmedikçe, tüm hakları saklı tutulmak şartıyla telif hakkı ile korunmaktadır.